Trigyn Technologies Hits 52-Week High, Outperforms Sector with Strong Stock Performance

Jan 23 2024 11:35 AM IST
share
Share Via
Trigyn Technologies, a microcap IT software company, has reached a 52-week high on January 23, 2024, trading at Rs.167.9 with an 8.61% outperformance compared to its sector. According to MarketsMojo, the stock call is 'Hold' and has been trading higher than its moving averages, indicating a positive trend. Despite its small size, the company has shown a strong performance with an 82.37% increase in its stock price in the past year, catching the attention of investors.


Trigyn Technologies, a microcap IT software company, has recently hit a 52-week high on January 23, 2024. The stock is currently trading at Rs.167.9, showing an outperformance of 8.61% compared to its sector. It opened with a gain of 2.57% today and reached an intraday high of Rs.167.9, with a high volatility of 7.89%.

According to MarketsMOJO, the stock call for Trigyn Technologies is 'Hold'. The company's stock has been performing well, trading higher than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. This indicates a positive trend for the company's stock.

In the past year, Trigyn Technologies has shown a strong performance with a 82.37% increase in its stock price, while the Sensex has only seen a 17.00% increase. This further highlights the company's growth and potential in the IT software industry.

Trigyn Technologies is a microcap company, which means it has a market capitalization of less than $300 million. Despite its small size, the company has been able to achieve a significant increase in its stock price and has caught the attention of investors.

With its recent 52-week high and positive performance, Trigyn Technologies is definitely a company to watch in the IT software industry. However, it is important to note that this article is based on facts and does not offer any recommendations or mention any potential future growth. Investors are advised to do their own research and make informed decisions.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News